Euroapi SAS
PAR:EAPI
Euroapi SAS
Total Equity
Euroapi SAS
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Euroapi SAS
PAR:EAPI
|
Total Equity
€983.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Sanofi SA
PAR:SAN
|
Total Equity
€74.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ipsen SA
PAR:IPN
|
Total Equity
€4.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
|
Vetoquinol SA
PAR:VETO
|
Total Equity
€543m
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Virbac SA
PAR:VIRP
|
Total Equity
€1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
|
Medincell SA
PAR:MEDCL
|
Total Equity
-€54m
|
CAGR 3-Years
-221%
|
CAGR 5-Years
-93%
|
CAGR 10-Years
N/A
|
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Total Equity?
Total Equity
983.5m
EUR
Based on the financial report for Dec 31, 2024, Euroapi SAS's Total Equity amounts to 983.5m EUR.
What is Euroapi SAS's Total Equity growth rate?
Total Equity CAGR 5Y
-1%
Over the last year, the Total Equity growth was 6%. The average annual Total Equity growth rates for Euroapi SAS have been -1% over the past three years , -1% over the past five years .
You don't have any saved screeners yet